Therapeutic potential of pro-resolving mediators in diabetic kidney disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic potential of pro-resolving mediators in diabetic kidney disease
Authors
Keywords
Tubulointerstitial fibrosis, Glomerulosclerosis, Hyperglycemia, Inflammation, Specialized pro-resolving mediators, Polyunsaturated fatty acids, Lipoxins
Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 178, Issue -, Pages 113965
Publisher
Elsevier BV
Online
2021-09-09
DOI
10.1016/j.addr.2021.113965
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential
- (2021) Monika Maciuszek et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Ac2-26-Nanoparticles Induce Resolution of Intestinal Inflammation and Anastomotic Healing via Inhibition of NF-κB Signaling in a Model of Perioperative Colitis
- (2021) Stefan Reischl et al. INFLAMMATORY BOWEL DISEASES
- NOX inhibition: Pre-clinical and clinical studies in diabetic complications
- (2020) Sofia Urner et al. ANTIOXIDANTS & REDOX SIGNALING
- Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2020) Rhys Williams et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials
- (2020) Api Chewcharat et al. PLoS One
- Structure of formylpeptide receptor 2-Gi complex reveals insights into ligand recognition and signaling
- (2020) Youwen Zhuang et al. Nature Communications
- Dual modulation of formyl peptide receptor 2 by aspirin‐triggered lipoxin contributes to its anti‐inflammatory activity
- (2020) Yunjun Ge et al. FASEB JOURNAL
- Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure
- (2020) Yoshikazu Asahina et al. JOURNAL OF MEDICINAL CHEMISTRY
- Associations between the Neutrophil-to-Lymphocyte Ratio and Diabetic Complications in Adults with Diabetes: A Cross-Sectional Study
- (2020) Heng Wan et al. Journal of Diabetes Research
- Resolvin D1 Protects Against Ischemia/Reperfusion-Induced Acute Kidney Injury by Increasing Treg Percentages via the ALX/FPR2 Pathway
- (2020) Hong Luan et al. Frontiers in Physiology
- Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis
- (2020) Letizia Crocetti et al. BIOORGANIC CHEMISTRY
- Randomized Clinical Trial on the Effect of Bardoxolone Methyl on GFR in Diabetic Kidney Disease Patients (TSUBAKI Study)
- (2020) Masaomi Nangaku et al. Kidney International Reports
- Formyl peptide receptor type 2 agonists to kick‐start resolution pharmacology
- (2020) Mauro Perretti et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Atlas of Inflammation Resolution (AIR)
- (2020) Charles N. Serhan et al. MOLECULAR ASPECTS OF MEDICINE
- Endothelium structure and function in kidney health and disease
- (2019) Noemie Jourde-Chiche et al. Nature Reviews Nephrology
- The Protectin Family of Specialized Pro-resolving Mediators: Potent Immunoresolvents Enabling Innovative Approaches to Target Obesity and Diabetes
- (2019) Trond Vidar Hansen et al. Frontiers in Pharmacology
- Maresin 1 mitigates renal ischemia/reperfusion injury in mice via inhibition of the TLR4/MAPK/ NF-κB pathways and activation of the Nrf2 pathway
- (2019) Yun Qiu et al. Drug Design Development and Therapy
- Macrophages: versatile players in renal inflammation and fibrosis
- (2019) Patrick Ming-Kuen Tang et al. Nature Reviews Nephrology
- Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
- (2019) Hiddo J. L. Heerspink et al. DIABETOLOGIA
- A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes
- (2019) Monika A. Niewczas et al. NATURE MEDICINE
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines
- (2019) Yihua Bai et al. MEDICAL SCIENCE MONITOR
- Functional and signaling characterization of the neutrophil FPR2 selective agonist Act-389949
- (2019) Simon Lind et al. BIOCHEMICAL PHARMACOLOGY
- Maresin 1 Mitigates Sepsis-Associated Acute Kidney Injury in Mice via Inhibition of the NF-κB/STAT3/MAPK Pathways
- (2019) ShuJun Sun et al. Frontiers in Pharmacology
- Mitigating risk of aldosterone in diabetic kidney disease
- (2019) Marie Frimodt-Møller et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- BML-111 attenuates high glucose-induced inflammation, oxidative stress and reduces extracellular matrix accumulation via targeting Nrf2 in rat glomerular mesangial cells
- (2019) Xiaoming Wu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Advanced Oxidation Protein Products Aggravate Tubulointerstitial Fibrosis Through Protein Kinase C-Dependent Mitochondrial Injury in Early Diabetic Nephropathy
- (2018) Xiao Li et al. ANTIOXIDANTS & REDOX SIGNALING
- Recombinant human GLP-1(rhGLP-1) alleviating renal tubulointestitial injury in diabetic STZ-induced rats
- (2018) Weiqin Yin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Role of the Immune System in Diabetic Kidney Disease
- (2018) Fionnuala B. Hickey et al. Current Diabetes Reports
- RAGE Deletion Confers Renoprotection by Reducing Responsiveness to Transforming Growth Factor-β and Increasing Resistance to Apoptosis
- (2018) Shinji Hagiwara et al. DIABETES
- A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes
- (2018) Natalie R. van Zuydam et al. DIABETES
- Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study
- (2018) Iain M. Carey et al. DIABETES CARE
- Immune responsive resolvin D1 programs myocardial infarction–induced cardiorenal syndrome in heart failure
- (2018) Ganesh V. Halade et al. FASEB JOURNAL
- GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain
- (2018) Sangsu Bang et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease
- (2018) Paul M Ridker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoxins Regulate the Early Growth Response–1 Network and Reverse Diabetic Kidney Disease
- (2018) Eoin P. Brennan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Advanced glycation end products in the pathogenesis of chronic kidney disease
- (2018) Naila Rabbani et al. KIDNEY INTERNATIONAL
- Renal tubule injury: a driving force toward chronic kidney disease
- (2018) Bi-Cheng Liu et al. KIDNEY INTERNATIONAL
- Lipoxin A4 may attenuate the progression of obesity-related glomerulopathy by inhibiting NF-κB and ERK/p38 MAPK-dependent inflammation
- (2018) Yan-Ping Guo et al. LIFE SCIENCES
- Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease
- (2018) Juan Jesus Carrero et al. Nature Reviews Nephrology
- JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
- (2018) Katherine R Tuttle et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial
- (2018) Milton Packer et al. Lancet Diabetes & Endocrinology
- Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
- (2018) Vlado Perkovic et al. Lancet Diabetes & Endocrinology
- Lipoxins Protect Against Inflammation in Diabetes-Associated Atherosclerosis
- (2018) E. P. Brennan et al. DIABETES
- Targeting strategies for drug delivery to the kidney: From renal glomeruli to tubules
- (2018) Chun-Ping Liu et al. MEDICINAL RESEARCH REVIEWS
- Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms)
- (2018) Monica de Gaetano et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of AT-RvD1 on paraquat-induced acute renal injury in mice
- (2018) Xiao Hu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Novel ureidopropanamide based N -formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation
- (2017) Madia Letizia Stama et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles
- (2017) Marilina Codagnone et al. FASEB JOURNAL
- Selective Nanoparticle Targeting of the Renal TubulesNovelty and Significance
- (2017) Ryan M. Williams et al. HYPERTENSION
- Regulation of inflammation by members of the formyl-peptide receptor family
- (2017) Keqiang Chen et al. JOURNAL OF AUTOIMMUNITY
- Astrocyte-derived lipoxins A4 and B4 promote neuroprotection from acute and chronic injury
- (2017) Izhar Livne-Bar et al. JOURNAL OF CLINICAL INVESTIGATION
- Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology
- (2017) Naveen K. Rajasagi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury
- (2017) Guangbi Li et al. JOURNAL OF LIPID RESEARCH
- A more tubulocentric view of diabetic kidney disease
- (2017) Letizia Zeni et al. JOURNAL OF NEPHROLOGY
- Maresin 1 Mitigates High Glucose-Induced Mouse Glomerular Mesangial Cell Injury by Inhibiting Inflammation and Fibrosis
- (2017) Shi Tang et al. MEDIATORS OF INFLAMMATION
- Signal transduction involved in lipoxin A4-induced protection of tubular epithelial cells against hypoxia/reoxygenation injury
- (2017) Sheng-Hua Wu et al. Molecular Medicine Reports
- Resveratrol-loaded nanoparticles conjugated with kidney injury molecule-1 as a drug delivery system for potential use in chronic kidney disease
- (2017) Yuh-Feng Lin et al. Nanomedicine
- B cells in type 1 diabetes mellitus and diabetic kidney disease
- (2017) Mia J. Smith et al. Nature Reviews Nephrology
- GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes
- (2017) Marcel H. A. Muskiet et al. Nature Reviews Nephrology
- White blood cell fractions correlate with lesions of diabetic kidney disease and predict loss of kidney function in Type 2 diabetes
- (2017) Kevin M Wheelock et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients
- (2017) Marian Goicoechea et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Pilot application of lipoxin A4 analog and lipoxin A4 receptor agonist in asthmatic children with acute episodes
- (2017) Xia Kong et al. Experimental and Therapeutic Medicine
- Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice
- (2017) Cheng Xue Qin et al. Nature Communications
- Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949
- (2016) Anna K. Stalder et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease
- (2016) Emilie Mas et al. CLINICAL NUTRITION
- Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes
- (2016) M. T. Coughlan et al. CLINICAL SCIENCE
- Podocytes: the Weakest Link in Diabetic Kidney Disease?
- (2016) Jamie S. Lin et al. Current Diabetes Reports
- Tapping into Mitochondria to Find Novel Targets for Diabetes Complications
- (2016) Nicole B. Flemming et al. CURRENT DRUG TARGETS
- Targeting inflammation in diabetic kidney disease: early clinical trials
- (2016) Maria Vanessa Perez-Gomez et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic Inflammation
- (2016) Hildur H. Arnardottir et al. JOURNAL OF IMMUNOLOGY
- Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
- (2016) James Voelker et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Resolution of inflammation: a new therapeutic frontier
- (2016) James N. Fullerton et al. NATURE REVIEWS DRUG DISCOVERY
- TGF-β: the master regulator of fibrosis
- (2016) Xiao-ming Meng et al. Nature Reviews Nephrology
- Macrophages in diabetic nephropathy in patients with type 2 diabetes
- (2016) Celine Q.F. Klessens et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epithelial Plasticity versus EMT in Kidney Fibrosis
- (2016) Shizheng Huang et al. TRENDS IN MOLECULAR MEDICINE
- Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
- (2016) Wenxia Lu et al. Gastroenterology Research and Practice
- Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial
- (2016) Hiddo J L Heerspink et al. Lancet Diabetes & Endocrinology
- Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis
- (2016) Fatima Khaja et al. Nanomaterials
- Characterizing the Interactions of Organic Nanoparticles with Renal Epithelial Cells in Vivo
- (2015) Anil V. Nair et al. ACS Nano
- Activation of annexin A1 signalling in renal fibroblasts exerts antifibrotic effects
- (2015) H. Neymeyer et al. Acta Physiologica
- Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease
- (2015) Emma Börgeson et al. Cell Metabolism
- 50 years forward: mechanisms of hyperglycaemia-driven diabetic complications
- (2015) Nicholas D. F. Russell et al. DIABETOLOGIA
- BML-111 Attenuates Renal Ischemia/Reperfusion Injury Via Peroxisome Proliferator-Activated Receptor-α-Regulated Heme Oxygenase-1
- (2015) Sheng-Hua Wu et al. INFLAMMATION
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Identification of resolvin D2 receptor mediating resolution of infections and organ protection
- (2015) Nan Chiang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial
- (2015) Richard L. Dunbar et al. Lipids in Health and Disease
- Mesoscale Nanoparticles Selectively Target the Renal Proximal Tubule Epithelium
- (2015) Ryan M. Williams et al. NANO LETTERS
- Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice
- (2015) Gabrielle Fredman et al. Science Translational Medicine
- BMP signalling: agony and antagony in the family
- (2015) Derek P. Brazil et al. TRENDS IN CELL BIOLOGY
- The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial
- (2015) Dick de Zeeuw et al. Lancet Diabetes & Endocrinology
- Diabetic kidney disease
- (2015) Merlin C. Thomas et al. Nature Reviews Disease Primers
- United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease
- (2015) Allan J. Collins et al. Kidney International Supplements
- Podocytes, Signaling Pathways, and Vascular Factors in Diabetic Kidney Disease
- (2014) Frank C. Brosius et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Endothelial nitric oxide synthase gene polymorphisms and risk of diabetic nephropathy: a systematic review and meta-analysis
- (2014) Bruno Schmidt Dellamea et al. BMC Medical Genetics
- Molecular mechanisms of diabetic kidney disease
- (2014) Kimberly Reidy et al. JOURNAL OF CLINICAL INVESTIGATION
- Cellular and molecular mechanisms in kidney fibrosis
- (2014) Jeremy S. Duffield JOURNAL OF CLINICAL INVESTIGATION
- Resolvin E1 Metabolome in Local Inactivation during Inflammation-Resolution
- (2014) S. Hong et al. JOURNAL OF IMMUNOLOGY
- Protective Actions of Aspirin-Triggered (17R) Resolvin D1 and Its Analogue, 17R-Hydroxy-19-Para-Fluorophenoxy-Resolvin D1 Methyl Ester, in C5a-Dependent IgG Immune Complex–Induced Inflammation and Lung Injury
- (2014) Huifang Tang et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Maresin-1 Engages Regulatory T Cells To Limit Type 2 Innate Lymphoid Cell Activation and Promote Resolution of Lung Inflammation
- (2014) Nandini Krishnamoorthy et al. JOURNAL OF IMMUNOLOGY
- FPR2/ALXR Agonists and the Resolution of Inflammation
- (2014) Olivier Corminboeuf et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Potential Role for Mechanical Forces in the Detachment of Podocytes and the Progression of CKD
- (2014) W. Kriz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The potential for renoprotection with incretin-based drugs
- (2014) Tetsuhiro Tanaka et al. KIDNEY INTERNATIONAL
- Pro-resolving lipid mediators are leads for resolution physiology
- (2014) Charles N. Serhan NATURE
- Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development
- (2014) Hyun Mi Kang et al. NATURE MEDICINE
- Maladaptive Proximal Tubule Repair: Cell Cycle Arrest
- (2014) Joseph V. Bonventre NEPHRON CLINICAL PRACTICE
- Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis
- (2014) Thomas Gobbetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4synthesis by inhibiting a calcium-activated kinase pathway
- (2014) Gabrielle Fredman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Maresin 1 biosynthesis during platelet–neutrophil interactions is organ-protective
- (2014) Raja-Elie E. Abdulnour et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury
- (2014) Jiao Chen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Primary proximal tubule injury leads to epithelial cell cycle arrest, fibrosis, vascular rarefaction, and glomerulosclerosis
- (2014) Joseph V. Bonventre Kidney International Supplements
- The Relationship Between Neutrophil Lymphocyte Ratio With Urinary Protein Albumin Excretion in Newly Diagnosed Patients With Type 2 Diabetes
- (2013) Baris Afsar AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?
- (2013) G C Higgins et al. BRITISH JOURNAL OF PHARMACOLOGY
- Vascular Complications of Diabetes: Mechanisms of Injury and Protective Factors
- (2013) Christian Rask-Madsen et al. Cell Metabolism
- The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview
- (2013) David M. Nathan et al. DIABETES CARE
- Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects
- (2013) M. F. Lopes-Virella et al. DIABETES CARE
- The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype
- (2013) Jesmond Dalli et al. FASEB JOURNAL
- Lipoxins Attenuate Renal Fibrosis by Inducing let-7c and Suppressing TGF R1
- (2013) E. P. Brennan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential
- (2013) Hiroki Fujita et al. KIDNEY INTERNATIONAL
- Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b
- (2013) Bo Wang et al. KIDNEY INTERNATIONAL
- Delivery materials for siRNA therapeutics
- (2013) Rosemary Kanasty et al. NATURE MATERIALS
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of Diabetic Complications
- (2013) Josephine M. Forbes et al. PHYSIOLOGICAL REVIEWS
- Connective Tissue Growth Factor (CTGF) Expression Modulates Response to High Glucose
- (2013) Leighton R. James et al. PLoS One
- Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles
- (2013) N. Kamaly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses
- (2013) S. N. Cooray et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipoxin A4 Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell Activation in Asthma
- (2013) C. Barnig et al. Science Translational Medicine
- Aberrant Recruitment and Activation of T Cells in Diabetic Nephropathy
- (2012) Ju-Young Moon et al. AMERICAN JOURNAL OF NEPHROLOGY
- Resolvin D1 Receptor Stereoselectivity and Regulation of Inflammation and Proresolving MicroRNAs
- (2012) Sriram Krishnamoorthy et al. AMERICAN JOURNAL OF PATHOLOGY
- Resolvin D1 Limits Polymorphonuclear Leukocyte Recruitment to Inflammatory Loci
- (2012) Lucy V. Norling et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Efficacy and safety of 15(R/S)-methyl-lipoxin A4in topical treatment of infantile eczema
- (2012) S.-H. Wu et al. BRITISH JOURNAL OF DERMATOLOGY
- Diabetes and Infection: Is There a Link? - A Mini-Review
- (2012) Sylvia Knapp GERONTOLOGY
- Specialized Proresolving Mediators Enhance Human B Cell Differentiation to Antibody-Secreting Cells
- (2012) S. Ramon et al. JOURNAL OF IMMUNOLOGY
- Resolvin E2 Formation and Impact in Inflammation Resolution
- (2012) S. F. Oh et al. JOURNAL OF IMMUNOLOGY
- Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation
- (2012) Xinli Qu et al. JOURNAL OF PATHOLOGY
- A Comparison of the Antihypertensive and Anti-Inflammatory Effects of Aliskiren and Ramipril Add-On Therapy in Peritoneal Dialysis Patients A Pilot Open Label Study
- (2012) Agnieszka Makówka et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Inflammation in Diabetic Nephropathy
- (2012) Andy K. H. Lim et al. MEDIATORS OF INFLAMMATION
- GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases
- (2012) Hari Hendarto et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Losartan prevents the development of the pro-inflammatory monocytes CD14+CD16+ in haemodialysis patients
- (2012) Ana Merino et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- VEGF and Podocytes in Diabetic Nephropathy
- (2012) Alda Tufro et al. SEMINARS IN NEPHROLOGY
- Oxidative Stress, Nox Isoforms and Complications of Diabetes—Potential Targets for Novel Therapies
- (2012) Mona Sedeek et al. Journal of Cardiovascular Translational Research
- New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes
- (2012) Niina Sandholm et al. PLoS Genetics
- Resolvins and Protectins in Inflammation Resolution
- (2011) Charles N. Serhan et al. CHEMICAL REVIEWS
- Novel Proresolving Aspirin-Triggered DHA Pathway
- (2011) Charles N. Serhan et al. CHEMISTRY & BIOLOGY
- Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy: FIG. 1.
- (2011) Judy B. de Haan DIABETES
- Deletion of platelet-derived growth factor receptor-β improves diabetic nephropathy in Ca2+/calmodulin-dependent protein kinase IIα (Thr286Asp) transgenic mice
- (2011) H. Suzuki et al. DIABETOLOGIA
- Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
- (2011) R. Kodera et al. DIABETOLOGIA
- Lipoxin A4 and benzo-lipoxin A4 attenuate experimental renal fibrosis
- (2011) Emma Börgeson et al. FASEB JOURNAL
- Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
- (2011) Markus Gödel et al. JOURNAL OF CLINICAL INVESTIGATION
- mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
- (2011) Ken Inoki et al. JOURNAL OF CLINICAL INVESTIGATION
- Comparative Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin-Receptor Blockade on Inflammation during Hemodialysis
- (2011) J. L. Gamboa et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Scar wars: mapping the fate of epithelial–mesenchymal–myofibroblast transition
- (2011) Susan E. Quaggin et al. KIDNEY INTERNATIONAL
- An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes
- (2011) Sufyan G. Sayyed et al. KIDNEY INTERNATIONAL
- Targeting kidney mesangium by nanoparticles of defined size
- (2011) C. H. J. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipoxin and Aspirin-Triggered Lipoxins
- (2011) Mario Romano TheScientificWorldJOURNAL
- Molecular Circuits of Resolution in Renal Disease
- (2011) Emma Börgeson et al. TheScientificWorldJOURNAL
- Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells☆
- (2010) M.E.M. Dolman et al. ADVANCED DRUG DELIVERY REVIEWS
- Lipoxin A4 Inhibits Transition of Epithelial to Mesenchymal Cells in Proximal Tubules
- (2010) Sheng-Hua Wu et al. AMERICAN JOURNAL OF NEPHROLOGY
- Tubular Overexpression of Transforming Growth Factor-β1 Induces Autophagy and Fibrosis but Not Mesenchymal Transition of Renal Epithelial Cells
- (2010) Robert Koesters et al. AMERICAN JOURNAL OF PATHOLOGY
- Insulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function
- (2010) Gavin I. Welsh et al. Cell Metabolism
- Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria
- (2010) S. G. Adler et al. Clinical Journal of the American Society of Nephrology
- Docosahexaenoic acid, protectins and dry eye
- (2010) Maria S Cortina et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis
- (2010) Paola Maderna et al. FASEB JOURNAL
- MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits
- (2010) Antonio Recchiuti et al. FASEB JOURNAL
- Glomerular Structure and Function Require Paracrine, Not Autocrine, VEGF-VEGFR-2 Signaling
- (2010) K. Sison et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Review Article: Review: Endothelial-myofibroblast transition, a new player in diabetic renal fibrosis
- (2010) JINHUA LI et al. NEPHROLOGY
- Resolvin D1 binds human phagocytes with evidence for proresolving receptors
- (2010) S. Krishnamoorthy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipoxins: resolutionary road
- (2009) Paola Maderna et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mechanisms of Podocyte Injury in Diabetes: Role of Cytochrome P450 and NADPH Oxidases
- (2009) A. A. Eid et al. DIABETES
- The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
- (2009) P.-H. Groop et al. DIABETES
- Angiotensin II Induces Connective Tissue Growth Factor and Collagen I Expression via Transforming Growth Factor–β–Dependent and –Independent Smad Pathways
- (2009) Fuye Yang et al. HYPERTENSION
- Biomarkers for epithelial-mesenchymal transitions
- (2009) Michael Zeisberg et al. JOURNAL OF CLINICAL INVESTIGATION
- Acute Changes in Dietary -3 and -6 Polyunsaturated Fatty Acids Have a Pronounced Impact on Survival following Ischemic Renal Injury and Formation of Renoprotective Docosahexaenoic Acid-Derived Protectin D1
- (2009) I. R. Hassan et al. JOURNAL OF IMMUNOLOGY
- Lipoxin A4: Anti-Inflammatory and Anti-Angiogenic Impact on Endothelial Cells
- (2009) N. Baker et al. JOURNAL OF IMMUNOLOGY
- 6-Methyl-2,4-Disubstituted Pyridazin-3(2H)-ones: A Novel Class of Small-Molecule Agonists for Formyl Peptide Receptors
- (2009) Agostino Cilibrizzi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Advanced Glycation End-Products Induce Tubular CTGF via TGF- -Independent Smad3 Signaling
- (2009) A. C.K. Chung et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Correlation between Circulating Adhesion Molecule Levels and Albuminuria in Type-2 Diabetic Hypertensive Patients
- (2009) Alberto Francisco Rubio-Guerra et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Pericytes and Perivascular Fibroblasts Are the Primary Source of Collagen-Producing Cells in Obstructive Fibrosis of the Kidney
- (2008) Shuei-Liong Lin et al. AMERICAN JOURNAL OF PATHOLOGY
- Anti-Inflammatory and Proresolving Lipid Mediators
- (2008) Charles N. Serhan et al. Annual Review of Pathology-Mechanisms of Disease
- Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties
- (2008) Nicos A. Petasis et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years: Association with mortality and decline of glomerular filtration rate
- (2008) A. S. Astrup et al. DIABETES CARE
- Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions
- (2008) Charles N. Serhan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Fibroblasts in Kidney Fibrosis Emerge via Endothelial-to-Mesenchymal Transition
- (2008) E. M. Zeisberg et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- UKPDS and the Legacy Effect
- (2008) John Chalmers et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transforming growth factor-β/connective tissue growth factor axis in the kidney
- (2007) Weier Qi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- A New Look at Platelet-Derived Growth Factor in Renal Disease
- (2007) J. Floege et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now